Q1/2021 3/31/2021 EPS -0.620 ZacksConsensus -0.510 ActVsEst (0.110) - Miss
SpringWorks Therapeutics, Inc. - common stock (SWTX)
Last springworks therapeutics, inc. - common stock earnings: 3/12 04:30 pm
Check Earnings Report
Company Research
Source: Wall Street Horizon
Impact Snapshot
Event Time:
SWTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SWTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SWTX alerts
High impacting SpringWorks Therapeutics, Inc. - common stock news events
Weekly update
A roundup of the hottest topics
SWTX
News
- SpringWorks Therapeutics to Report First Quarter 2024 Financial Results Thursday, May 2, 2024 [Yahoo! Finance]Yahoo! Finance
- SpringWorks Therapeutics to Report First Quarter 2024 Financial Results Thursday, May 2, 2024GlobeNewswire
- SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) had its price target raised by analysts at HC Wainwright from $73.00 to $74.00. They now have a "buy" rating on the stock.MarketBeat
- SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) had its price target raised by analysts at JPMorgan Chase & Co. from $73.00 to $74.00. They now have an "overweight" rating on the stock.MarketBeat
- SpringWorks Therapeutics Initiates Rolling Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN [Yahoo! Finance]Yahoo! Finance
SWTX
Earnings
- 11/2/23 - Beat
SWTX
Sec Filings
- 4/5/24 - Form ARS
- 4/5/24 - Form DEFA14A
- 4/5/24 - Form DEF
- SWTX's page on the SEC website